Gastroparesis Drugs Market Trends

• The demand for the treatment of gastroparesis fuels research and development activities in the pharmaceutical industry, leading to the introduction of new drugs tailored to address the symptoms and underlying causes of gastroparesis. For instance, as per an article published in National Institute of Health in August 2022, it has been reported that prevalence of gastroparesis is 267.7 per 100,000 adults in the U.S. However, a population?based estimate suggests that up to 1.8% of the population is affected. Therefore, as awareness about gastroparesis improves among healthcare professionals and patients, there is greater diagnosis and treatment-seeking behavior, further propelling the demand for gastroparesis drugs.